🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tejaswini Kulkarni

University of Alabama at Birmingham

ORCID: 0000-0002-4251-4988

Also affiliated with Pulmonary and Allergy Associates

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis”.

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis

BMC Pulmonary Medicine(2024)10.1186/s12890-024-02957-3

N/A

0.669DataRank · unranked

14 citations

Gerard J. Criner, Daniel J. Kass, Iván O. Rosas, Mary Beth Scholand, Daniel F. Dilling +3 more

Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution

JCI Insight(2020)10.1172/jci.insight.134539

N/A

0DataRank · unranked

86 citations

Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu +3 more

Citrullinated vimentin mediates development and progression of lung fibrosis

Science Translational Medicine(2021)10.1126/scitranslmed.aba2927

N/A

0DataRank · unranked

119 citations

Ranu Surolia, Huashi Li, Zheng Wang, Gang Liu, Tejaswini Kulkarni +13 more

Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations

PLoS ONE(2021)10.1371/journal.pone.0260345

N/A

0DataRank · unranked

19 citations

Vincent G. Valentine, Fei Fei, Thi K. Tran-Nguyen, Luisa D. Quesada-Arias, Takudzwa Mkorombindo +6 more

Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

The Medicine Forum(2024)10.21203/rs.3.rs-3962419/v1

N/A

0DataRank · unranked

0 citations

Gerard J. Criner, Daniel J. Kass, Iván O. Rosas, Mary Beth Scholand, Daniel F. Dilling +3 more

TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity

Nature Communications(2025)10.1038/s41467-025-57024-0

N/A

0DataRank · unranked

52 citations

Sami Banerjee, Na Xie, Musaddique Hussain, Ashish Jaiswal, Hongli Liu +6 more